135 related articles for article (PubMed ID: 17041000)
1. Mitomycin- and calcineurin-associated HUS, endothelial dysfunction and endothelial repair: a new paradigm for the puzzle?
Shah R; Beem E; Sautina L; Zharikov SI; Segal MS
Nephrol Dial Transplant; 2007 Feb; 22(2):617-20. PubMed ID: 17041000
[No Abstract] [Full Text] [Related]
2. [Mitomycin-induced hemolytic uremia syndrome].
Steffens F
Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
[No Abstract] [Full Text] [Related]
3. Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy.
Groff JA; Kozak M; Boehmer JP; Demko TM; Diamond JR
Am J Kidney Dis; 1997 Feb; 29(2):280-4. PubMed ID: 9016902
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C-related hemolytic uremic syndrome in cancer patients.
Schiebe ME; Hoffmann W; Belka C; Bamberg M
Anticancer Drugs; 1998 Jun; 9(5):433-5. PubMed ID: 9660541
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.
Catalano C; Gianesini C; Fabbian F
Nephron; 2002 Jun; 91(2):324-6. PubMed ID: 12053072
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome.
Camp-Sorrell D
Oncol Nurs Forum; 2008 Jul; 35(4):593-6. PubMed ID: 18591164
[No Abstract] [Full Text] [Related]
7. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
[TBL] [Abstract][Full Text] [Related]
8. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
[No Abstract] [Full Text] [Related]
9. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Wu DC; Liu JM; Chen YM; Yang S; Liu SM; Chen LT; Whang-Peng J
Jpn J Clin Oncol; 1997 Apr; 27(2):115-8. PubMed ID: 9152802
[TBL] [Abstract][Full Text] [Related]
11. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
[TBL] [Abstract][Full Text] [Related]
12. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin-C induced hemolytic uremic syndrome: a case report.
Gundappa RK; Sud K; Kohli HS; Gupta KL; Joshi K; Sakhuja V
Ren Fail; 2002 May; 24(3):373-7. PubMed ID: 12166705
[TBL] [Abstract][Full Text] [Related]
14. [Hemolytic-uremic syndrome caused by mitomycin C].
de Insausti CL; Gutiérrez LE
Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
[No Abstract] [Full Text] [Related]
15. [Mitomycin-induced hemolytic-uremic syndrome].
Zeller G; Wandel E; Schwarting A
Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
[TBL] [Abstract][Full Text] [Related]
16. [Drug induced hemolytic uremic syndrome].
Ito K; Komatsu Y
Nihon Rinsho; 1993 Jan; 51(1):204-9. PubMed ID: 7679450
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin C-induced pulmonary and renal toxicities.
Loprinzi CL
Wis Med J; 1984 Mar; 83(3):16-7. PubMed ID: 6428065
[No Abstract] [Full Text] [Related]
18. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell JE; Phillips TM; Schein PS
J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy.
Torra R; Poch E; Torras A; Bombí JA; Revert L
Chemotherapy; 1993; 39(6):453-6. PubMed ID: 8222875
[TBL] [Abstract][Full Text] [Related]
20. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
Crocker J; Jones EL
J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
